FAM151B
Protein FAM151B
Also known as: F151B_HUMAN, UNQ9217
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXP7
- Gene
- FAM151B
- Ensembl
- ENSG00000152380
- Chromosome
- 5
- Canonical length
- 276 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to be involved in photoreceptor cell development. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
276 residues, UniProt reviewed canonical sequence.
>Q6UXP7|FAM151B
1 MAASAGGPGS WSENILEYFL RNSQITAEDG AEITWYHAAN HKAQTNEALK STAHMIEADV
61 LLPSDGSEHS QPIMAHPPET NSDNTLQEWL TEVMKSNKGI KLDFKSLAVV EPSMMLLENV
121 KRHLKRPVWI NADILPGPNG NSKVIDAKPF LDTVISFFPD VTFSLGWTTG WHPEKVNEGY
181 SWTMVKEMEY ICNELSQPVT FPVRAALVRQ SCSQLLWLLK KSNRYSLTIW TGKNDNYSVE
241 DLLYIRDHFD KKQVFYDILE PQNHEFKQAI GIKVNLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM151B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 4.4 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 4.4 nTPM
- placenta: 1.7 nTPM
- fallopian tube: 1.2 nTPM
- kidney: 1.1 nTPM
- adrenal gland: 1 nTPM
- cerebral cortex: 1 nTPM
Single-cell type
- neutrophil progenitors: 179 nCPM
- neutrophils: 89 nCPM
- ependymal cells: 54 nCPM
- syncytiotrophoblasts: 46 nCPM
- cytotrophoblasts: 40 nCPM
- adrenal cortex cells: 36 nCPM
Immune cell
- myeloid DC: 1 nTPM
- eosinophil: 0.5 nTPM
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.3 nTPM
- non-classical monocyte: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- hippocampal formation: 3.3 nTPM
- cerebral cortex: 3.1 nTPM
- hypothalamus: 3.1 nTPM
- basal ganglia: 2.7 nTPM
- white matter: 2.7 nTPM
- amygdala: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM151B as an antibody target. Whether an autoantibody or antibody against FAM151B could matter depends on whether native FAM151B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM151B is annotated as secreted, so native FAM151B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FAM151B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...